Search
for
Sort by
Research 61–90 of 517
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous Manifestations of Eating Disorders
- Cutaneous Reactions in Patients with Chronic Hepatitis C Treated with Peginterferon and Ribavirin
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Chemotherapy and Cutaneous Drug Reactions
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- S-1 induced discoid lupus erythematosus-like lesions and long-term complete response for para-aortic lymph node recurrence of pancreatic ductal adenocarcinoma: a case report
- ACUTE ZINC DEPLETION SYNDROME DURING PARENTERAL HYPERALIMENTATION
- Skin disorders associated with the COVID‐19 pandemic: A review
- Acquired Zinc Deficiency
- A systematic review of dermatologic manifestations among adult patients with COVID‐19 diagnosis
- A novel mutation in the FERMT1 gene in a Spanish family with Kindler’s syndrome
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Molecular pathology of skin adnexal tumours
- Mechanical forces in skin disorders
- Innovative Uses for Zinc in Dermatology
- <i>Pten</i> loss in Lgr5<sup>+</sup> hair follicle stem cells promotes SCC development
- How Coronavirus Disease 2019 Changed Dermatology Practice in 1 Year Around the World
- Dermatological Manifestations of COVID-19 Patients
- Generalized Pustular Psoriasis
- Dermatological adverse events with taxane chemotherapy
- Anatomic location of primary melanoma: Survival differences and sun exposure
- Dermoscopy: distinguishing malignant tumors from benign
- Partial regrowth of scalp hair in a patient treated with extracorporeal pholtochemotherapy and interferon ? 2a
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Clinical Management in Psychodermatology
- Spotlight commentary: Navigating the cutaneous side effects of chemotherapy